Referral pathways and diagnosis: UK government actions fail to recognize complexity of lymphoma

被引:7
作者
Howell, D. A. [1 ]
Smith, A. G. [1 ]
Roman, E. [1 ]
机构
[1] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England
关键词
lymphoma; referral pathways; diagnosis; delay; haematology;
D O I
10.1111/j.1365-2354.2007.00789.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To gain survival advantages potentially associated with prompt diagnosis, the UK government introduced identical waiting-time targets for all cancers, and guidelines to ensure that general practitioners make appropriate hospital referrals. For lymphoma, the evidence guiding these actions is limited. This study examined referral pathways in patients with lymphoma and variations in time to diagnosis by discipline of first referral. A case series study was conducted including all patients aged over 25 years, newly diagnosed with lymphoma in the UK county of West Yorkshire, during 2000. Data were extracted from primary care and hospital records of 189 patients. Referral pathways were described, and the number of days between first referral and diagnosis calculated. A distinct referral pathway did not exist; patients were initially referred to many disciplines. Surgical referrals predominated, and only 12% of patients were sent directly to haematology. Time to diagnosis varied by discipline and was shorter for patients sent to haematology than for most other common disciplines. UK government actions to ensure the prompt diagnosis of patients with lymphoma are not evidence-based. The complexity of the referral pathway in patients with lymphoma, which affects time to diagnosis, has been underestimated. Further government actions should be evidence-based, ensuring prompt diagnosis of lymphoma from whatever discipline patients originate.
引用
收藏
页码:529 / 532
页数:4
相关论文
共 8 条
[1]  
[Anonymous], 1997, The New NHS: Modern, Dependable
[2]   Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients [J].
Chau, I ;
Kelleher, MT ;
Cunningham, D ;
Norman, AR ;
Wotherspoon, A ;
Trott, P ;
Rhys-Evans, P ;
Della Rovere, GQ ;
Brown, G ;
Allen, M ;
Waters, JS ;
Haque, S ;
Murray, T ;
Bishop, L .
BRITISH JOURNAL OF CANCER, 2003, 88 (03) :354-361
[3]  
*DH, 2006, REF GUID SUSP CANC
[4]  
DH Department of Health, 2000, NHS CANC PLAN PLAN I
[5]   Lymphoma: variations in time to diagnosis and treatment [J].
Howell, D. A. ;
Smith, A. G. ;
Roman, E. .
EUROPEAN JOURNAL OF CANCER CARE, 2006, 15 (03) :272-278
[6]  
National Institute for Clinical Excellence (NICE), 2003, GUID COMM CANC SERV
[7]   The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma [J].
Richards, SJ ;
Jack, AS .
CLINICAL AND LABORATORY HAEMATOLOGY, 2003, 25 (06) :337-342
[8]   An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom [J].
Summerfield, GP ;
Carey, PJ ;
Galloway, MJ ;
Tinegate, HN .
CLINICAL AND LABORATORY HAEMATOLOGY, 2000, 22 (03) :157-160